Erythema: FDA reporting patterns
202,551 FDA FAERS reports mention Erythema. 92,796 reports have a serious outcome flag.
Medicines named as suspect
- Adapalene: 39,512 reports
- Avobenzone: 34,488 reports
- Octisalate: 34,471 reports
- Octocrylene: 31,009 reports
- Dupilumab: 13,528 reports
- Adalimumab: 7,294 reports
- Etanercept: 6,914 reports
- Infliximab: 5,043 reports
- Niacin: 4,156 reports
- Homosalate: 3,560 reports
- Oxybenzone: 3,553 reports
- Octinoxate: 3,531 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.